| scholarly article | Q13442814 |
| P50 | author | Jeffrey Eastham-Anderson | Q87191291 |
| P2093 | author name string | Patricia Hamilton | |
| Deepak Sampath | |||
| Richard A D Carano | |||
| Jason Oeh | |||
| Thomas O'Brien | |||
| Franklin V Peale | |||
| Yunzhou Shi | |||
| Maj Hedehus | |||
| Anna Hitz | |||
| P2860 | cites work | Targeting the hypoxic fraction of tumours using hypoxia-activated prodrugs | Q26774750 |
| Quantifying antivascular effects of monoclonal antibodies to vascular endothelial growth factor: insights from imaging | Q27346895 | ||
| SR-4233: a new bioreductive agent with high selective toxicity for hypoxic mammalian cells | Q28303921 | ||
| Multimodal microvascular imaging reveals that selective inhibition of class I PI3K is sufficient to induce an antivascular response | Q28384680 | ||
| Hypoxia--a key regulatory factor in tumour growth | Q29547318 | ||
| Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy | Q29547379 | ||
| Targeting hypoxia in cancer therapy | Q29615491 | ||
| Tumor oximetry: demonstration of an enhanced dynamic mapping procedure using fluorine-19 echo planar magnetic resonance imaging in the Dunning prostate R3327-AT1 rat tumor | Q32149224 | ||
| Cross-species vascular endothelial growth factor (VEGF)-blocking antibodies completely inhibit the growth of human tumor xenografts and measure the contribution of stromal VEGF. | Q33226862 | ||
| Bevacizumab-induced tumor vessel remodeling in rhabdomyosarcoma xenografts increases the effectiveness of adjuvant ionizing radiation | Q33995820 | ||
| Scheduling of radiation with angiogenesis inhibitors anginex and Avastin improves therapeutic outcome via vessel normalization. | Q34039409 | ||
| In vivo observation of intracellular oximetry in perfluorocarbon-labeled glioma cells and chemotherapeutic response in the CNS using fluorine-19 MRI. | Q34249620 | ||
| Automatic nuclei segmentation in H&E stained breast cancer histopathology images | Q34906509 | ||
| Targeting the tumour vasculature: exploitation of low oxygenation and sensitivity to NOS inhibition by treatment with a hypoxic cytotoxin | Q35034825 | ||
| Antiangiogenic agents increase breast cancer stem cells via the generation of tumor hypoxia | Q35779246 | ||
| SR 4233 (tirapazamine): a new anticancer drug exploiting hypoxia in solid tumours | Q35976983 | ||
| Increased antitumor activity of bevacizumab in combination with hypoxia inducible factor-1 inhibition | Q37349436 | ||
| Mapping in vivo tumor oxygenation within viable tumor by 19F-MRI and multispectral analysis | Q37382526 | ||
| Antiangiogenic therapy, hypoxia, and metastasis: risky liaisons, or not? | Q37883011 | ||
| Overcoming disappointing results with antiangiogenic therapy by targeting hypoxia | Q38004740 | ||
| Imaging hypoxia to improve radiotherapy outcome | Q38059626 | ||
| Rapid monitoring of oxygenation by 19F magnetic resonance imaging: Simultaneous comparison with fluorescence quenching | Q39903373 | ||
| MRI of perfluorocarbon emulsion kinetics in rodent mammary tumours | Q40333684 | ||
| Quantification of tumor tissue populations by multispectral analysis | Q40581417 | ||
| Assessing early therapeutic response to bevacizumab in primary breast cancer using magnetic resonance imaging and gene expression profiles | Q45046819 | ||
| Vessel imaging with viable tumor analysis for quantification of tumor angiogenesis | Q46207764 | ||
| Rapid tissue oxygen tension mapping using 19F inversion-recovery echo-planar imaging of perfluoro-15-crown-5-ether. | Q52374376 | ||
| Anti-Vascular endothelial growth factor treatment augments tumor radiation response under normoxic or hypoxic conditions. | Q54033425 | ||
| Non-invasive determination of tumor oxygen tension and local variation with growth | Q57574396 | ||
| Quantification of viable tumor microvascular characteristics by multispectral analysis. | Q64936571 | ||
| In vitro activity of the benzotriazine dioxide SR 4233 against human tumour colony-forming units | Q70478858 | ||
| P433 | issue | 11 | |
| P304 | page(s) | 950-959 | |
| P577 | publication date | 2017-10-05 | |
| P1433 | published in | Neoplasia | Q2962042 |
| P1476 | title | Monitoring and Targeting Anti-VEGF Induced Hypoxia within the Viable Tumor by 19F-MRI and Multispectral Analysis | |
| P478 | volume | 19 |
| Q99711979 | Application of IVIM-DWI in Detecting the Tumor Vasculogenic Mimicry Under Antiangiogenesis Combined With Oxaliplatin Treatment |
| Q91789276 | Immune-Mediated Antitumor Effect By VEGFR2 Selective Inhibitor For Gastric Cancer |
| Q91981643 | Strategies to Interfere with Tumor Metabolism through the Interplay of Innate and Adaptive Immunity |
Search more.